# Emotional suppression and depressive symptoms in women newly diagnosed with early breast cancer

**Authors:** Lingyan Li, Yanjie Yang, Jincai He, Jinyao Yi, Yuping Wang, Jinqiang Zhang, Xiongzhao Zhu

PMC · DOI: 10.1186/s12905-015-0254-6 · BMC Women's Health · 2015-10-24

## TL;DR

Chinese women newly diagnosed with early breast cancer often experience high levels of depressive symptoms, which are linked to emotional suppression, especially anger suppression.

## Contribution

This study is the first to examine emotional suppression and its association with depressive symptoms in Chinese women newly diagnosed with early breast cancer.

## Key findings

- 36.4% of newly diagnosed women reported clinical depressive symptoms, and 36.0% reported severe depressive symptoms.
- Patients with breast cancer scored significantly higher on emotional suppression than healthy women.
- Anger suppression was a significant predictor of depressive symptoms in these patients.

## Abstract

Patients with breast cancer usually present varying levels of depressive symptoms. Emotional suppression, as a coping style, refers to an individual’s ability to consciously control expression of negative emotions. Thus, emotional suppression is an important psychological factor related to depressive symptoms in patients with breast cancer. It has long been considered that compared to European and American women, Chinese women are more likely to ascribe to norms of negative emotion control for smooth social interaction. However, there is paucity of research focusing on emotional suppression among Chinese women with breast cancer. Thus the aims of the current study were (1) to investigate the incidence of depressive symptoms in women newly diagnosed with early breast cancer in Mainland China, and (2) to examine the relationships between emotional suppression and depressive symptoms in these patients.

The Center for Epidemiological Studies Depression Scale (CES-D), the Beck Anxiety Inventory (BAI) and the Chinese version of the Courtauld Emotional Control Scale (CECS) were used to assess the level of depressive symptoms, anxiety symptoms and emotional suppression respectively in 247 women with early breast cancer and 362 healthy women. Analyses of variance were conducted to investigate group differences on depressive symptoms and emotional suppression. Bivariate correlations and Hierarchical regression analyses were performed to examine the effect of emotional suppression on depressive symptoms in participants after controlling the impact of group membership and anxiety level.

(1) The incidence rates of clinical and severe depressive symptoms in patients were 36.4 and 36.0 % respectively. (2) Patients scored significantly higher than healthy women on CECS. (3) The scores on CECS were significantly associated with the total CES-D scores in all participants; Anger suppression significantly predicted the total CES-D scores.

The majority of women newly diagnosed with early breast cancer reported clinical or severe depressive symptoms. As well, these patients presented a controlled emotion coping style. Emotional suppression was associated with the level of depressive symptoms in women newly diagnosed with breast cancer. Anger suppression might play a unique role in the depressive symptoms among women newly diagnosed with breast cancer.

## Linked entities

- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Diseases:** Breast cancer (MESH:D001943), died (MESH:D003643), psychosocial maladjustment (MESH:C535569), psychiatric (MESH:D001523), Depression (MESH:D003866), cardiac (MESH:D006331), Anxiety (MESH:D001007), CES-D (MESH:C538175), cancer (MESH:D009369), neurological disorders (MESH:D009461), substance abuse (MESH:D019966), Emotional suppression (MESH:D000550), emotional (MESH:D003072), pain (MESH:D010146), Anxiety Symptoms (MESH:D001008)
- **Chemicals:** BAI (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4620014/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC4620014/full.md

---
Source: https://tomesphere.com/paper/PMC4620014